The Angiogenesis Foundation

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
The Angiogenesis Foundation
Non-profit
Founded1994 in Cambridge, MA
FounderWilliam W. Li, MD
HeadquartersCambridge, MA, U.S.
Revenue1,772,286 US dollar (2017) Edit this on Wikidata
Websiteangio.org

The Angiogenesis Foundation, is a United States 501(c)(3) nonprofit organization established in 1994 for the study of angiogenesis. The founders were former students of Dr. Judah Folkman, a pioneer of angiogenesis research.

The foundation focuses on treatments in the areas of cancer, cardiology, wound healing, dermatology, and ophthalmology.

The foundation developed a therapy for canine cancer, called the Navy Protocol. This treatment works by starving the tumor of its blood supply.[1]

In 1998, the Foundation led the establishment of angiogenic growth factor therapy as the first advanced treatment for diabetic foot ulcers.[citation needed] In 2004, they helped publicly launch the first antiangiogenic therapy for cancer, bevacizumab, starting with colorectal cancer,[2][failed verification] and later broadening to breast, lung, liver, kidney, and brain cancers.

External links[edit]

References[edit]